7 predictions for the next 12 months
-
Transformers replace recurrent networks to learn world models with which RL agents surpass human
performance in large and rich game environments .
-
ASML’s market cap reaches $500B.
-
Anthropic publishes on the level of GPT, Dota, AlphaGo to establish itself as a third pole of AGI research.
-
A wave of consolidation in AI semiconductors with at least one of Graphcore, Cerebras, SambaNova, Groq, or
Mythic being acquired by a large technology company or major semiconductor incumbent.
-
Small transformers + CNN hybrid models match current SOTA on ImageNet top-1 accuracy (CoAtNet-7,
90.88%, 2.44B params) with 10x fewer parameters.
-
DeepMind releases a major research breakthrough in the physical sciences.
-
The JAX framework grows from 1% to 5% of monthly repos created as measured by PapersWithCode.
stateof.ai 2021
Morrie is concerned about where will growth come from.
When I look at the blistering pace of AI development, I am more concerned about how society can culturally keep up with AI forced changes.
In other words, to me, it seems like we are growing faster than ever.
We wanted flying cars, instead, we got 140 characters of AI-generated text that can pass the Turing test.
"Originally, it was researched for the treatment of diabetes, but development was not continued for this application due to poor results in testing.
Subsequently, halicin was identified by artificial intelligence researchers at the MIT Jameel Clinic in 2019 using an in silico deep learning approach, as a likely broad-spectrum antibiotic. This likelihood was verified by in vitro cell culture testing, followed by in vivo tests in mice. It showed activity against drug-resistant strains of Clostridiodes difficile, Acinetobacter baumannii, and Mycobacterium tuberculosis, with an unusual mechanism of action involving the sequestration of iron inside the bacterial cells, that thereby interferes with their ability to regulate the pH balance across the cell membrane properly. Since this is a different mode of action from most antibiotics, halicin retained activity against bacterial strains resistant to many commonly used drugs."